Evidence map›Paper›PMID 27880772›Full record

ArticlePloS one2016

T Cell Production of IFNγ in Response to TLR7/IL-12 Stimulates Optimal B Cell Responses to Viruses.

Kira Rubtsova, Anatoly V Rubtsov, Kalani Halemano, Sam X Li, John W Kappler, Mario L Santiago, Philippa Marrack

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 54 citations in OpenAlex.

  1. Injury polarized CD4Redox biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. T-betNature communications · 2024
    Article
  8. Article
  9. Investigating the Role of T-betMediterranean journal of rheumatology · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. STAT1 and Its Crucial Role in the Control of Viral Infections.International journal of molecular sciences · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kira RubtsovaHoward Hughes Medical Institute, Denver, Colorado, 80206, United States of America.
Anatoly V RubtsovHoward Hughes Medical Institute, Denver, Colorado, 80206, United States of America.
Kalani HalemanoDepartment of Medicine, University of Colorado Denver, Aurora, Colorado 80045, United States of America.
Sam X LiDepartment of Medicine, University of Colorado Denver, Aurora, Colorado 80045, United States of America.
John W KapplerHoward Hughes Medical Institute, Denver, Colorado, 80206, United States of America.
Mario L SantiagoDepartment of Medicine, University of Colorado Denver, Aurora, Colorado 80045, United States of America.
Philippa MarrackHoward Hughes Medical Institute, Denver, Colorado, 80206, United States of America.
University of Colorado Denver · USNational Jewish Health · USUniversity of Colorado Anschutz Medical Campus · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
Molecular Pathogenesis of Infectious DiseasesT32AI052066 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2002 to 2022
$2.3M
CHARACTERISTICS OF T-CELL RECEPTORSR37AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1992 to 2001
$522k
Immunological impact of Tetherin retrovirus restrictionR21AI112418 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SANTIAGO, MARIO LUIS · 2014 to 2015
$427k
Characteristics of T Cell ReceptorsR56AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2012 to 2012
$410k
NIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI018785NIAID NIH HHS R21 AI112418NIAID NIH HHS R37 AI018785NIAID NIH HHS R56 AI018785NIAID NIH HHS T32 AI052066NIAID NIH HHS T32 AI074491
6 · The paper itself

Abstract

Knowledge of the processes that underlie IgG subclass switching could inform strategies designed to counteract infections and autoimmunity. Here we show that TLR7 ligands induce subsets of memory CD4 and CD8 T cells to secrete interferon γ (IFNγ) in the absence of antigen receptor stimulation. In turn, TLR ligation and IFNγ cause B cells to express the transcription factor, T-bet, and to switch immunoglobulin production to IgG2a/c. Absence of TLR7 in T cells leads to the impaired T-bet expression in B cells and subsequent inefficient IgG2a isotype switching both in vitro and during the infection with Friend virus in vivo. Our results reveal a surprising mechanism of antiviral IgG subclass switching through T-cell intrinsic TLR7/IL-12 signaling.

Indexed as

AnimalsB-LymphocytesBone Marrow CellsCells, CulturedEnzyme-Linked Immunosorbent AssayFriend murine leukemia virusImidazolesImmunoglobulin GInterferon-gammaInterleukin-12MiceMice, Inbred C57BLMyeloid Differentiation Factor 88Signal TransductionSpleenT-LymphocytesImidazolesImmunoglobulin GInterferon-gammaInterleukin-12Myeloid Differentiation Factor 88resiquimodToll-Like Receptor 7

Identifiers

PMID27880772
PMCPMC5120817
OpenAlexW2552037968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.